翰思艾泰生物医药科技（武汉）股份有限公司（股票代码：03378）于2026年4月14日公告，2026年4月10日在香港联交所场内回购2.37万股H股普通股，占公司已发行股本约0.017%。每股回购价介乎港币29.50元至30.66元，涉及总金额约71.54万港元。
本次回购后，公司已发行股份数目从136,132,730股减少至136,109,030股，库藏股数量增至109,800股。
回购依据于2026年2月12日获得通过的授权进行，该授权可回购股份总数为13,621,883股，截至目前已回购109,800股。公司确认已遵守香港联交所上市规则及相关法律法规。公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.